comparemela.com

Latest Breaking News On - Novabay pharmaceuticals inc - Page 2 : comparemela.com

Short Interest in NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Drops By 77.7%

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report) was the recipient of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 30,500 shares, a decline of 77.7% from the April 30th total of 137,000 shares. Based on an average daily trading volume, of 8,110,000 […]

United-states
Novabay-pharmaceuticals-price-performance
Novabay-pharmaceuticals
Avenova-eye-health
News-ratings-for-novabay-pharmaceuticals-daily
Novabay-pharmaceuticals-inc
Get-free-report
Bay-pharmaceuticals
Avenova-spray
Avenova-eye-health-support
Avenova-lubricating-eye-drops

NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates

NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United-states
New-york
American
Novabay-avenova
Justin-hall
Avenova-allograft
Computershare-inc
Exchange-commission
Avenova-eye-health
American-company-guide-section
American-company
Facebook

StockNews.com Begins Coverage on NovaBay Pharmaceuticals (NYSE:NBY)

StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Free Report) in a research note published on Saturday morning. The brokerage issued a sell rating on the stock. NovaBay Pharmaceuticals Stock Down 5.9 % Shares of NYSE:NBY opened at $0.13 on Friday. NovaBay Pharmaceuticals has a 12 month low of $0.07 and a 12 […]

United-states
Novabay-pharmaceuticals-inc
Exchange-commission
Armistice-capital
Novabay-pharmaceuticals-stock-down
News-ratings-for-novabay-pharmaceuticals-daily
Institutional-investors-weigh-in-on-novabay-pharmaceuticals
Novabay-pharmaceuticals-company-profile
Novabay-pharmaceuticals
Free-report
Bay-pharmaceuticals-stock-down

NovaBay Pharmaceuticals (NYSE:NBY) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Free Report) in a research report sent to investors on Saturday morning. The brokerage issued a sell rating on the stock. NovaBay Pharmaceuticals Price Performance Shares of NYSE NBY opened at $0.13 on Friday. The company has a 50 day simple moving average of $0.10 […]

United-states
Novabay-pharmaceuticals
Armistice-capital
Novabay-pharmaceuticals-price-performance
Exchange-commission
Novabay-pharmaceuticals-inc
News-ratings-for-novabay-pharmaceuticals-daily
Free-report
Bay-pharmaceuticals
Get-free-report
Avenova-spray

StockNews.com Initiates Coverage on NovaBay Pharmaceuticals (NYSE:NBY)

Analysts at StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a “sell” rating on the stock. NovaBay Pharmaceuticals Stock Down 5.9 % NYSE:NBY opened at $0.13 on Friday. The business’s 50-day simple moving average is $0.10 […]

United-states
News-ratings-for-novabay-pharmaceuticals-daily
Novabay-pharmaceuticals-inc
Hedge-funds-weigh-in-on-novabay-pharmaceuticals
Novabay-pharmaceuticals-stock-down
Armistice-capital
Exchange-commission
Novabay-pharmaceuticals
Get-free-report
Bay-pharmaceuticals-stock-down
Bay-pharmaceuticals

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.